Christopher Simon - 18 May 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Reporting relationship: President & CEO, Director
Issuer ticker: HAE
Reported as of: 18 May 2023
Net transaction value: -$319,942
SEC form: 4
Accepted by SEC: 19 May 2023, 16:32:53 UTC
Prior SEC filing: 17 May 2023
Next SEC filing: 30 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. Simon

Key filing fact

Christopher Simon filed Form 4 for HAEMONETICS CORP (HAE) on 19 May 2023.

Key facts

This page summarizes Christopher Simon's Form 4 filing for HAEMONETICS CORP (HAE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 May 2023, 16:32.

Change

Previous filing in this sequence was filed on 17 May 2023.
Current net transaction value: -$319,942.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HAE transaction

Common Stock

Tax liability

Transaction value: $319,942
Shares: -3,839
Change %: -1.7%
Price: $83.34
Shares after: 217,367
Date: 18 May 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

Footnote F2

This number includes unvested restricted stock units previously reported.